Mesenchymal Stem Cells in Action

As of March 2020, all of the clinical trials that utilize our products are managed by the Hope Biosciences Stem Cells Research Foundation. HBSCRF exists to revolutionize medicine by accelerating translational research in regenerative medicine to develop cures for all. To date, HBSCRF has obtained FDA authorization for 22 clinical studies in 12 disease areas.